Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $707.34 million. The enterprise value is $529.39 million.
| Market Cap | 707.34M |
| Enterprise Value | 529.39M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, before market open.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 67.43 million shares outstanding. The number of shares has increased by 116.59% in one year.
| Shares Outstanding | 67.43M |
| Shares Change (YoY) | +116.59% |
| Shares Change (QoQ) | +76.28% |
| Owned by Insiders (%) | 20.44% |
| Owned by Institutions (%) | 39.71% |
| Float | 40.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.08 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.98, with a Debt / Equity ratio of 0.01.
| Current Ratio | 12.98 |
| Quick Ratio | 12.54 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -531.34 |
Financial Efficiency
Return on equity (ROE) is -45.60% and return on invested capital (ROIC) is -18.35%.
| Return on Equity (ROE) | -45.60% |
| Return on Assets (ROA) | -38.50% |
| Return on Capital (ROIC) | -18.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$503,629 |
| Employee Count | 116 |
| Asset Turnover | -0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CATX has paid $7.85 million in taxes.
| Income Tax | 7.85M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.27% in the last 52 weeks. The beta is 1.43, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.43 |
| 52-Week Price Change | +52.27% |
| 50-Day Moving Average | 14.27 |
| 200-Day Moving Average | 8.31 |
| Relative Strength Index (RSI) | 41.68 |
| Average Volume (20 Days) | 1,340,679 |
Short Selling Information
The latest short interest is 2.34 million, so 3.48% of the outstanding shares have been sold short.
| Short Interest | 2.34M |
| Short Previous Month | 1.36M |
| Short % of Shares Out | 3.48% |
| Short % of Float | 5.75% |
| Short Ratio (days to cover) | 3.49 |
Income Statement
In the last 12 months, CATX had revenue of -$304,000 and -$58.42 million in losses. Loss per share was -$1.90.
| Revenue | -304,000 |
| Gross Profit | 1.27M |
| Operating Income | -42.72M |
| Pretax Income | -50.57M |
| Net Income | -58.42M |
| EBITDA | -49.22M |
| EBIT | -50.48M |
| Loss Per Share | -$1.90 |
Balance Sheet
The company has $180.83 million in cash and $2.88 million in debt, giving a net cash position of $177.95 million or $2.64 per share.
| Cash & Cash Equivalents | 180.83M |
| Total Debt | 2.88M |
| Net Cash | 177.95M |
| Net Cash Per Share | $2.64 |
| Equity (Book Value) | 229.89M |
| Book Value Per Share | 3.41 |
| Working Capital | 173.70M |
Cash Flow
In the last 12 months, operating cash flow was -$13.34 million and capital expenditures -$9.94 million, giving a free cash flow of -$23.29 million.
| Operating Cash Flow | -13.34M |
| Capital Expenditures | -9.94M |
| Free Cash Flow | -23.29M |
| FCF Per Share | -$0.47 |
Margins
Gross margin is -418.42%, with operating and profit margins of 14,052.30% and 19,217.43%.
| Gross Margin | -418.42% |
| Operating Margin | 14,052.30% |
| Pretax Margin | 16,635.53% |
| Profit Margin | 19,217.43% |
| EBITDA Margin | 16,191.78% |
| EBIT Margin | 16,604.28% |
| FCF Margin | 7,659.54% |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -116.59% |
| Shareholder Yield | -116.59% |
| Earnings Yield | -8.26% |
| FCF Yield | -3.29% |
Analyst Forecast
The average price target for CATX is $22.00, which is 109.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.00 |
| Price Target Difference | 109.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 78.02% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CATX has an Altman Z-Score of 8.09 and a Piotroski F-Score of 3.
| Altman Z-Score | 8.09 |
| Piotroski F-Score | 3 |